FI120697B - Kohonneen termofiilisyyden ja alkalofiilisyyden sisältävät modifioidut ryhmä 11 -ksylanaasit - Google Patents
Kohonneen termofiilisyyden ja alkalofiilisyyden sisältävät modifioidut ryhmä 11 -ksylanaasit Download PDFInfo
- Publication number
- FI120697B FI120697B FI20022120A FI20022120A FI120697B FI 120697 B FI120697 B FI 120697B FI 20022120 A FI20022120 A FI 20022120A FI 20022120 A FI20022120 A FI 20022120A FI 120697 B FI120697 B FI 120697B
- Authority
- FI
- Finland
- Prior art keywords
- trx
- xylanase
- hml
- amino acid
- modified
- Prior art date
Links
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 title claims description 345
- 150000001413 amino acids Chemical class 0.000 claims description 72
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 49
- 125000000539 amino acid group Chemical group 0.000 claims description 36
- 241000499912 Trichoderma reesei Species 0.000 claims description 19
- 230000002378 acidificating effect Effects 0.000 claims description 16
- 101000756530 Aspergillus niger Endo-1,4-beta-xylanase B Proteins 0.000 claims description 15
- 230000001976 improved effect Effects 0.000 claims description 12
- 241001557886 Trichoderma sp. Species 0.000 claims description 5
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 claims description 4
- 101710132690 Endo-1,4-beta-xylanase A Proteins 0.000 claims description 4
- 241000187747 Streptomyces Species 0.000 claims description 4
- 241000223261 Trichoderma viride Species 0.000 claims description 4
- 101000781264 Streptomyces lividans Endo-1,4-beta-xylanase B Proteins 0.000 claims description 3
- 101000805012 Streptomyces lividans Endo-1,4-beta-xylanase C Proteins 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 description 101
- 102000004190 Enzymes Human genes 0.000 description 100
- 108090000790 Enzymes Proteins 0.000 description 100
- 229940088598 enzyme Drugs 0.000 description 100
- 230000000694 effects Effects 0.000 description 97
- 230000035772 mutation Effects 0.000 description 87
- 239000013612 plasmid Substances 0.000 description 71
- 239000000047 product Substances 0.000 description 43
- 230000002255 enzymatic effect Effects 0.000 description 40
- 102220550870 Fumarate hydratase, mitochondrial_N29L_mutation Human genes 0.000 description 35
- 102220576120 Oligodendrocyte transcription factor 1_Y27W_mutation Human genes 0.000 description 35
- 239000013615 primer Substances 0.000 description 29
- 229920001221 xylan Polymers 0.000 description 27
- 150000004823 xylans Chemical class 0.000 description 27
- 102220553875 Cytidine and dCMP deaminase domain-containing protein 1_Q125A_mutation Human genes 0.000 description 23
- 238000011534 incubation Methods 0.000 description 22
- 238000000034 method Methods 0.000 description 22
- 239000002243 precursor Substances 0.000 description 20
- 108091034117 Oligonucleotide Proteins 0.000 description 18
- 108091008146 restriction endonucleases Proteins 0.000 description 18
- 238000010276 construction Methods 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 16
- 238000012217 deletion Methods 0.000 description 15
- 230000037430 deletion Effects 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 238000006467 substitution reaction Methods 0.000 description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 description 14
- 102220276401 rs149059494 Human genes 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 241000223259 Trichoderma Species 0.000 description 11
- 239000001913 cellulose Substances 0.000 description 11
- 229920002678 cellulose Polymers 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000002209 hydrophobic effect Effects 0.000 description 10
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 238000004061 bleaching Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 101710163270 Nuclease Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 238000012219 cassette mutagenesis Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 238000004076 pulp bleaching Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 101710101924 Endo-1,4-beta-xylanase 1 Proteins 0.000 description 5
- 101710101928 Endo-1,4-beta-xylanase 2 Proteins 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- -1 amino - Chemical class 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 125000002883 imidazolyl group Chemical group 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 238000006366 phosphorylation reaction Methods 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 241001131785 Escherichia coli HB101 Species 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 3
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 241000193445 [Clostridium] stercorarium Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000005693 branched-chain amino acids Chemical class 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000005546 dideoxynucleotide Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000004537 pulping Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 102200080796 rs104894868 Human genes 0.000 description 3
- 102220340464 rs1555191603 Human genes 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- XSXYESVZDBAKKT-UHFFFAOYSA-N 2-hydroxybenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1O XSXYESVZDBAKKT-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000193752 Bacillus circulans Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 241000834102 Ailia Species 0.000 description 1
- 241000122821 Aspergillus kawachii Species 0.000 description 1
- 101100421135 Caenorhabditis elegans sel-5 gene Proteins 0.000 description 1
- 241000178334 Caldicellulosiruptor Species 0.000 description 1
- 241000178335 Caldicellulosiruptor saccharolyticus Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000186321 Cellulomonas Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 1
- 101000801882 Dictyostelium discoideum Putative thioredoxin-5 Proteins 0.000 description 1
- 101000801880 Dictyostelium discoideum Thioredoxin-3 Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000605898 Fibrobacter Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 101000926206 Homo sapiens Putative glutathione hydrolase 3 proenzyme Proteins 0.000 description 1
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000203622 Nocardiopsis Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102220617426 Protein LSM14 homolog A_I29E_mutation Human genes 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 102100034060 Putative glutathione hydrolase 3 proenzyme Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000192031 Ruminococcus Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 241000203780 Thermobifida fusca Species 0.000 description 1
- 241000203640 Thermomonospora Species 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 101710168651 Thioredoxin 1 Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- PCBOWMZAEDDKNH-HOTGVXAUSA-N [4-(trifluoromethoxy)phenyl]methyl (3as,6as)-2-(3-fluoro-4-sulfamoylbenzoyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1=C(F)C(S(=O)(=O)N)=CC=C1C(=O)N1C[C@H]2CN(C(=O)OCC=3C=CC(OC(F)(F)F)=CC=3)C[C@@H]2C1 PCBOWMZAEDDKNH-HOTGVXAUSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000008045 co-localization Effects 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- CFZXDJWFRVEWSR-BUHFOSPRSA-N indigo carmine (acid form) Chemical compound N/1C2=CC=C(S(O)(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)O)C=C2C1=O CFZXDJWFRVEWSR-BUHFOSPRSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000013492 plasmid preparation Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 101150072359 trx gene Proteins 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
- C12N9/2482—Endo-1,4-beta-xylanase (3.2.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Paper (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21380300P | 2000-05-31 | 2000-05-31 | |
| US21380300 | 2000-05-31 | ||
| CA0100769 | 2001-05-31 | ||
| PCT/CA2001/000769 WO2001092487A2 (fr) | 2000-05-31 | 2001-05-31 | Xylanases modifiees presentant un caractere thermophile et alcalophile accru |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20022120A7 FI20022120A7 (fi) | 2002-12-02 |
| FI120697B true FI120697B (fi) | 2010-01-29 |
Family
ID=22796573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20022120A FI120697B (fi) | 2000-05-31 | 2002-12-02 | Kohonneen termofiilisyyden ja alkalofiilisyyden sisältävät modifioidut ryhmä 11 -ksylanaasit |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20030166236A1 (fr) |
| AU (1) | AU2001267171A1 (fr) |
| BR (1) | BR0111316A (fr) |
| CA (1) | CA2410917C (fr) |
| FI (1) | FI120697B (fr) |
| SE (1) | SE525279C2 (fr) |
| WO (1) | WO2001092487A2 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20031060L (fi) | 2001-01-18 | 2003-09-11 | Iogen Bio Produckts Corp | Ksylanaasikäsittelymenetelmiä valkaisussa |
| US7510860B1 (en) * | 2001-11-21 | 2009-03-31 | National Research Council Of Canada | Xylanases with enhanced thermophilicity and alkalophilicity |
| CA2477847A1 (fr) | 2002-03-06 | 2003-09-12 | Iogen Bio-Products Corporation | Traitement de pate chimique par des xylanases |
| KR20080045764A (ko) * | 2002-06-14 | 2008-05-23 | 신젠타 파티서페이션즈 아게 | 자일라나제, 이를 암호화하는 핵산, 및 이의 제조 및 사용방법 |
| BRPI0509168A (pt) | 2004-03-25 | 2007-09-11 | Iogen Bio Products Corp | xilanases modificadas que exibem expressão melhorada |
| WO2007115391A1 (fr) * | 2006-04-12 | 2007-10-18 | National Research Council Of Cananda | Modification de xylanases permettant d'améliorer la thermophilie, la thermostabilité et l'alcalophilie |
| RU2464313C2 (ru) * | 2006-04-12 | 2012-10-20 | Нэйшенл Рисерч Каунсил Оф Кэнэда | Модифицированная ксиланаза |
| BRPI0817811A2 (pt) * | 2007-10-03 | 2014-10-14 | Verenium Corp | Xilanases, ácidos nucleicos que codificam as mesmas e métodos para fabricação e uso das mesmas. |
| WO2010072226A1 (fr) | 2008-12-23 | 2010-07-01 | Danisco A/S | Polypeptides dotés d'une activité xylanase |
| EP2784161B1 (fr) | 2011-11-25 | 2018-06-20 | Mitsui Chemicals, Inc. | Xylanase mutante, procédé de fabrication et utilisation de celle-ci, et procédé de fabrication de lignocellulose saccharifiée |
| CN103627686B (zh) * | 2013-11-14 | 2015-03-18 | 青岛蔚蓝生物集团有限公司 | 一种木聚糖酶突变体及其应用 |
| CA2950273C (fr) | 2014-05-30 | 2022-06-21 | Novozymes A/S | Variants de xylanases de la famille gh11 et polynucleotides codant ces variants |
| GB2567010A (en) | 2017-10-02 | 2019-04-03 | Univ Strathclyde | Apparatus for the rehabilitation, assistance and/or augmentation of arm strength in a user |
| CN109971738B (zh) * | 2017-12-28 | 2020-09-04 | 中粮集团有限公司 | 木聚糖酶AnXyn10C的T32R突变体及其制备方法和用途 |
| KR102677156B1 (ko) * | 2021-08-06 | 2024-06-20 | 씨제이제일제당 주식회사 | 자일라나제 활성을 갖는 변이형 폴리펩티드 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2573854B2 (ja) * | 1987-12-12 | 1997-01-22 | 日興バイオ技研株式会社 | 超精密装置の超精密洗浄方法 |
| GB9018426D0 (en) | 1990-08-22 | 1990-10-03 | Sandoz Ltd | Improvements in or relating to novel compounds |
| US5405769A (en) | 1993-04-08 | 1995-04-11 | National Research Council Of Canada | Construction of thermostable mutants of a low molecular mass xylanase |
| EP0728197A1 (fr) | 1993-11-05 | 1996-08-28 | Cornell Research Foundation, Inc. | XYLANASE THERMOSTABLE PROVENANT D'UN GENE DE $i(THERMOMONOSPORA FUSCA) |
| JP3435946B2 (ja) | 1994-12-21 | 2003-08-11 | 王子製紙株式会社 | 耐熱性キシラナーゼ |
| US5759840A (en) * | 1996-09-09 | 1998-06-02 | National Research Council Of Canada | Modification of xylanase to improve thermophilicity, alkalophilicity and thermostability |
| DK1131447T4 (da) | 1998-11-16 | 2011-12-19 | Ca Nat Research Council | Termostabile xylanaser |
| US6682923B1 (en) * | 1999-05-12 | 2004-01-27 | Xencor | Thermostable alkaliphilic xylanase |
| US7510860B1 (en) | 2001-11-21 | 2009-03-31 | National Research Council Of Canada | Xylanases with enhanced thermophilicity and alkalophilicity |
-
2001
- 2001-05-31 WO PCT/CA2001/000769 patent/WO2001092487A2/fr not_active Ceased
- 2001-05-31 AU AU2001267171A patent/AU2001267171A1/en not_active Abandoned
- 2001-05-31 BR BR0111316-0A patent/BR0111316A/pt not_active Application Discontinuation
- 2001-05-31 CA CA2410917A patent/CA2410917C/fr not_active Expired - Fee Related
-
2002
- 2002-12-02 US US10/307,441 patent/US20030166236A1/en not_active Abandoned
- 2002-12-02 SE SE0203555A patent/SE525279C2/sv not_active IP Right Cessation
- 2002-12-02 FI FI20022120A patent/FI120697B/fi not_active IP Right Cessation
-
2006
- 2006-03-17 US US11/377,644 patent/US7695947B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20090325267A1 (en) | 2009-12-31 |
| AU2001267171A1 (en) | 2001-12-11 |
| US7695947B2 (en) | 2010-04-13 |
| CA2410917C (fr) | 2012-11-27 |
| US20030166236A1 (en) | 2003-09-04 |
| SE525279C2 (sv) | 2005-01-25 |
| WO2001092487A9 (fr) | 2002-12-05 |
| CA2410917A1 (fr) | 2001-12-06 |
| WO2001092487A3 (fr) | 2002-09-26 |
| SE0203555L (sv) | 2003-01-29 |
| FI20022120A7 (fi) | 2002-12-02 |
| WO2001092487A2 (fr) | 2001-12-06 |
| SE0203555D0 (sv) | 2002-12-02 |
| BR0111316A (pt) | 2003-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2002000B1 (fr) | Modification de xylanases permettant d'améliorer la thermophilie, la thermostabilité et l'alcalophilie | |
| FI120697B (fi) | Kohonneen termofiilisyyden ja alkalofiilisyyden sisältävät modifioidut ryhmä 11 -ksylanaasit | |
| EP0828002B1 (fr) | Modification du xylanase pour l'amélioration du thermophilicité, alkophilicité et thermostabilité | |
| CN101528929B (zh) | 具有提高的热稳定性、嗜热性和嗜碱性的家族6纤维素酶 | |
| FI122936B (fi) | Ksylanaaseja, joilla on lisääntynyt termofiilisyys ja alkalifiilisyys | |
| AU775311B2 (en) | Thermostable xylanases | |
| Karita et al. | Cellulose-binding domains confer an enhanced activity against insoluble cellulose to Ruminococcus albus endoglucanase IV | |
| JPH08501444A (ja) | 組換えキシラナーゼ | |
| Kaneko et al. | Purification and characterization of a family G/11 β-xylanase from Streptomyces olivaceoviridis E-86 | |
| Georis et al. | Sequence, overproduction and purification of the family 11 endo-β-1, 4-xylanase encoded by the xyl1 gene of Streptomyces sp. S38 | |
| Yuan | Genetic Improvement of Xylanase | |
| Khan | Molecular Characterisation of the Xylanolytic System in Phanerochaete chrysosporium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 120697 Country of ref document: FI |
|
| MM | Patent lapsed |